Carter HB - Search Results

1

Clearance rate of serum-free and total PSA following radical retropubic prostatectomy.

Partin AW, Piantadosi S, Subong EN, Kelly CA, Hortopan S, Chan DW, Wolfert RL, Rittenhouse HG, Carter HB. Partin AW, et al. Among authors: carter hb. Prostate Suppl. 1996;7:35-9. Prostate Suppl. 1996. PMID: 8950362

2

The relationship of prostate specific antigen levels and residual tumor volume in stage A prostate cancer.

Carter HB, Partin AW, Epstein JI, Chan DW, Walsh PC. Carter HB, et al. J Urol. 1990 Nov;144(5):1167-70; discussion 1170-1. doi: 10.1016/s0022-5347(17)39683-0. J Urol. 1990. PMID: 1700143

3

Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases.

Partin AW, Pearson JD, Landis PK, Carter HB, Pound CR, Clemens JQ, Epstein JI, Walsh PC. Partin AW, et al. Among authors: carter hb. Urology. 1994 May;43(5):649-59. doi: 10.1016/0090-4295(94)90180-5. Urology. 1994. PMID: 7513108

4

The use of prostate-specific antigen and free/total prostate-specific antigen in the diagnosis of localized prostate cancer.

Partin AW, Carter HB. Partin AW, et al. Among authors: carter hb. Urol Clin North Am. 1996 Nov;23(4):531-40. doi: 10.1016/s0094-0143(05)70333-5. Urol Clin North Am. 1996. PMID: 8948408 Free article. Review.

5

Longitudinal analysis of serial measurements of free and total PSA among men with and without prostatic cancer.

Pearson JD, Luderer AA, Metter EJ, Partin AW, Chan DW, Fozard JL, Carter HB. Pearson JD, et al. Among authors: carter hb. Urology. 1996 Dec;48(6A Suppl):4-9. doi: 10.1016/s0090-4295(96)00603-6. Urology. 1996. PMID: 8973693 Free article.

6

The role of free/total prostate-specific antigen ratio in the prediction of final pathologic stage for men with clinically localized prostate cancer.

Pannek J, Subong EN, Jones KA, Marschke PL, Epstein JI, Chan DW, Carter HB, Luderer AA, Partin AW. Pannek J, et al. Among authors: carter hb. Urology. 1996 Dec;48(6A Suppl):51-4. doi: 10.1016/s0090-4295(96)00610-3. Urology. 1996. PMID: 8973700 Free article. Clinical Trial.

7

Prostate-specific antigen in men born with bladder exstrophy.

Silver RI, Partin AW, Epstein JI, Chan DW, Carter HB, Jeffs RD, Gearhart JP. Silver RI, et al. Among authors: carter hb. Urology. 1997 Feb;49(2):253-6. doi: 10.1016/S0090-4295(96)00438-4. Urology. 1997. PMID: 9037290 Free article.

8

Percentage of free prostate-specific antigen in sera predicts aggressiveness of prostate cancer a decade before diagnosis.

Carter HB, Partin AW, Luderer AA, Metter EJ, Landis P, Chan DW, Fozard JL, Pearson JD. Carter HB, et al. Urology. 1997 Mar;49(3):379-84. doi: 10.1016/s0090-4295(96)00629-2. Urology. 1997. PMID: 9123702 Free article.

9

Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings.

Epstein JI, Chan DW, Sokoll LJ, Walsh PC, Cox JL, Rittenhouse H, Wolfert R, Carter HB. Epstein JI, et al. Among authors: carter hb. J Urol. 1998 Dec;160(6 Pt 2):2407-11. J Urol. 1998. PMID: 9817393 Free article. Review.

10

Influence of age and prostate-specific antigen on the chance of curable prostate cancer among men with nonpalpable disease.

Carter HB, Epstein JI, Partin AW. Carter HB, et al. Urology. 1999 Jan;53(1):126-30. doi: 10.1016/s0090-4295(98)00466-x. Urology. 1999. PMID: 9886601 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

305 results

Search Page

Filters